We are live on
!
Find out more
PAMU
Pictet Asset Management (UK) Portfolio holdings
AUM
$91.8B
1-Year Est. Return
47.77%
This Fund
S&P 500
This Quarter
Est. Return
+1.02%
1 Year Est. Return
+47.77%
3 Year Est. Return
+102.96%
5 Year Est. Return
+189.45%
10 Year Est. Return
–
AUM
$40.5B
AUM Growth
+$1.67B
(+4.3%)
Cap. Flow
+$1.77B
Cap. Flow
% of AUM
4.37%
Top 10 Holdings %
Top 10 Hldgs %
11.99%
Holding
924
New
37
Increased
379
Reduced
384
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$154M |
| 2 |
PayPal
PYPL
|
+$129M |
| 3 |
WP
Worldpay, Inc.
WP
|
+$119M |
| 4 |
Union Pacific
UNP
|
+$105M |
| 5 |
Meta Platforms (Facebook)
META
|
+$82.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Southern Company
SO
|
+$105M |
| 2 |
HDS
HD Supply Holdings, Inc.
HDS
|
+$92.4M |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$88.9M |
| 4 |
Intel
INTC
|
+$71.2M |
| 5 |
Amazon
AMZN
|
+$58.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.01% |
| 2 | Healthcare | 18.64% |
| 3 | Industrials | 12.41% |
| 4 | Consumer Discretionary | 10.04% |
| 5 | Utilities | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYNH
726
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.4M | 0.01% |
95,674
-150,480
| -61% | -$5.89M |
|
727
Marvell Technology
MRVL
$191B
| $3.39M | 0.01% |
161,567
-2,100
| -1% | -$48.1K |
|
728
Kimco Realty
KIM
$16.1B
| $3.39M | 0.01% |
235,525
-3,600
| -2% | -$55.4K |
|
729
Wabtec
WAB
$50.3B
| $3.37M | 0.01% |
41,435
| – | – |
|
730
iShares International Developed Real Estate ETF
IFGL
$82.2M
| $3.36M | 0.01% |
113,000
+6,000
| +6% | +$180K |
|
731
Chemours
CC
$2.23B
| $3.32M | 0.01% |
68,200
+10,700
| +19% | +$535K |
|
732
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
| $3.24M | 0.01% |
43,580
-15,500
| -26% | -$1.19M |
|
|
GHDX
733
DELISTED
Genomic Health, Inc.
GHDX
| $3.23M | 0.01% |
103,400
+13,800
| +15% | +$458K |
|
734
AGNC Investment
AGNC
$12.9B
| $3.22M | 0.01% |
170,182
-73,769
| -30% | -$1.4M |
|
735
Leidos
LDOS
$17.7B
| $3.21M | 0.01% |
49,161
-3,300
| -6% | -$218K |
|
|
MDCO
736
DELISTED
Medicines Co
MDCO
| $3.21M | 0.01% |
+97,600
| New | +$3.05M |
|
737
Advanced Energy
AEIS
$13.1B
| $3.21M | 0.01% |
+50,250
| New | +$3.47M |
|
738
News Corp Class A
NWSA
$15.5B
| $3.2M | 0.01% |
202,556
-4,700
| -2% | -$77.3K |
|
739
Jones Lang LaSalle
JLL
$16.7B
| $3.19M | 0.01% |
18,272
-700
| -4% | -$112K |
|
|
ICPT
740
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $3.17M | 0.01% |
+51,600
| New | +$3.11M |
|
|
ACOR
741
DELISTED
Acorda Therapeutics
ACOR
| $3.17M | 0.01% |
1,116
+198
| +22% | +$593K |
|
|
EGRX
742
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.15M | 0.01% |
59,700
+29,400
| +97% | +$1.71M |
|
|
VMW
743
DELISTED
VMware, Inc
VMW
| $3.13M | 0.01% |
25,810
| – | – |
|
|
DISCK
744
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $3.1M | 0.01% |
158,889
+33,304
| +27% | +$746K |
|
745
Veeva Systems
VEEV
$38.4B
| $3.07M | 0.01% |
42,002
+1,100
| +3% | +$71.1K |
|
746
Old Dominion Freight Line
ODFL
$43.4B
| $3.03M | 0.01% |
61,800
+11,100
| +22% | +$526K |
|
|
CIT
747
DELISTED
CIT Group Inc.
CIT
| $3.01M | 0.01% |
58,483
+500
| +0.9% | +$26.3K |
|
748
HF Sinclair
DINO
$15.2B
| $3M | 0.01% |
61,376
-1,700
| -3% | -$80.9K |
|
|
LPT
749
DELISTED
Liberty Property Trust
LPT
| $3M | 0.01% |
75,450
| – | – |
|
750
Pacira BioSciences
PCRX
$972M
| $3M | 0.01% |
96,215
+64,552
| +204% | +$2.3M |
|
Similar funds
QI
FRBONY
ICOM
BAIA
BPB
BAPIM
PWA
UR
Pictet Asset Management (UK)'s Q1 2018 Portfolio in Review
As of Q1 2018, Pictet Asset Management (UK) held 924 positions worth $40.5B, up 4.3% from $38.9B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Pictet Asset Management (UK) deployed $1.77B of net new capital in Q1 2018, opening 37 new positions and adding to 379 existing holdings. Its largest new stake was Nektar Therapeutics: 32,593 shares worth $52M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Southern Company, an estimated $105M trimmed.
- Pictet Asset Management (UK)'s largest Q1 2018 buy was Nektar Therapeutics: 32,593 shares worth $52M.
- Pictet Asset Management (UK) added most to Lam Research in Q1 2018, an estimated $154M increase.
- Pictet Asset Management (UK)'s biggest Q1 2018 reduction was Southern Company, cutting an estimated $105M.
- Pictet Asset Management (UK) fully exited Deltic Timber in Q1 2018, selling an estimated $38.8M.
- Pictet Asset Management (UK)'s ten largest holdings make up 12% of its $40.5B portfolio in Q1 2018.
- Pictet Asset Management (UK) opened 37 new positions and closed 31 in Q1 2018.
- Pictet Asset Management (UK)'s portfolio value rose 4.3% quarter-over-quarter to $40.5B.
Based on Pictet Asset Management (UK)'s 13F filing for Q1 2018, filed 25 Apr 2018.